A Study to Assess the Efficacy and Safety of AKST4290 With Aflibercept in Patients With Newly Diagnosed nAMD
Clinical trial NCT04331730 · COMPLETED
Trial details
- NCT number
- NCT04331730
- Sponsor
- Alkahest, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-28
- Primary completion
- 2021-08-19
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.